AP2002002401A0 - Histamine receptor antagonists. - Google Patents

Histamine receptor antagonists.

Info

Publication number: AP2002002401A0
Authority: AP; ARIPO
Prior art keywords: histamine; receptor antagonists; histamine receptor; receptor; antagonist
Prior art date: 2001-01-17

Application number

APAP/P/2002/002401A

Other languages

English (en)

Inventor

Stephen Jenkinson

Mark Anthony O'reilly

Michael Andrew Trevethick

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-01-17

Filing date

2002-01-17

Publication date

2002-03-31

2002-01-17 Application filed by Pfizer filed Critical Pfizer

2002-03-31 Publication of AP2002002401A0 publication Critical patent/AP2002002401A0/en

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Pulmonology (AREA)
Immunology (AREA)
Epidemiology (AREA)
Otolaryngology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

APAP/P/2002/002401A 2001-01-17 2002-01-17 Histamine receptor antagonists. AP2002002401A0 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB0101223.6A GB0101223D0 (en)	2001-01-17	2001-01-17	Histamine receptor antagonists

Publications (1)

Publication Number	Publication Date
AP2002002401A0 true AP2002002401A0 (en)	2002-03-31

Family

ID=9906993

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
APAP/P/2002/002401A AP2002002401A0 (en)	2001-01-17	2002-01-17	Histamine receptor antagonists.

Country Status (32)

Country	Link
EP (1)	EP1353657A1 (pl)
JP (1)	JP2004517883A (pl)
KR (1)	KR20030069216A (pl)
CN (1)	CN1486178A (pl)
AP (1)	AP2002002401A0 (pl)
AR (1)	AR032101A1 (pl)
BG (1)	BG107834A (pl)
BR (1)	BR0206502A (pl)
CA (1)	CA2435121A1 (pl)
CR (1)	CR6983A (pl)
CZ (1)	CZ20031853A3 (pl)
DO (1)	DOP2002000325A (pl)
EA (1)	EA200300537A1 (pl)
EC (1)	ECSP034692A (pl)
EE (1)	EE200300335A (pl)
GB (1)	GB0101223D0 (pl)
GT (1)	GT200200003A (pl)
HU (1)	HUP0302767A2 (pl)
IL (1)	IL156087A0 (pl)
IS (1)	IS6818A (pl)
MA (1)	MA26980A1 (pl)
MX (1)	MXPA03006408A (pl)
NO (1)	NO20033223D0 (pl)
OA (1)	OA12440A (pl)
PA (1)	PA8537101A1 (pl)
PL (1)	PL362793A1 (pl)
PY (1)	PY0200477A (pl)
SK (1)	SK8572003A3 (pl)
SV (1)	SV2003000849A (pl)
TN (1)	TNSN02003A1 (pl)
WO (1)	WO2002056871A2 (pl)
ZA (1)	ZA200304180B (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20030133931A1 (en) *	2001-12-21	2003-07-17	Robin Thurmond	Use of histamine H4 receptor antagonist for the treatment of inflammatory responses
EP1545596A4 (en) *	2002-09-06	2005-12-28	Janssen Pharmaceutica Nv	USE OF HISTAMINE H4 RECEPTOR MODULATORS FOR THE TREATMENT OF ALLERGIES AND ASTHMA
WO2004066960A2 (en) *	2003-01-28	2004-08-12	Schering Corporation	Combination of h1, h3 and h4 receptor antagonists for treatment of allergic and non-allergic pulmonary inflammation, congestion and allergic rhinitis
US8236786B2 (en)	2008-08-07	2012-08-07	Pulmagen Therapeutics (Inflammation) Limited	Respiratory disease treatment
WO2013151982A1 (en)	2012-04-03	2013-10-10	Arena Pharmaceuticals, Inc.	Methods and compounds useful in treating pruritus, and methods for identifying such compounds
HUE039713T2 (hu)	2012-06-08	2019-02-28	Sensorion	H4 receptor inhibitorok tinnitus kezelésére
CN119823227B (zh) *	2025-01-14	2025-07-04	广州迪卡德营养科技有限公司	一种益生菌的制备方法及其在治疗过敏性鼻炎中的用途

2001
- 2001-01-17 GB GBGB0101223.6A patent/GB0101223D0/en not_active Ceased
2002
- 2002-01-10 EA EA200300537A patent/EA200300537A1/ru unknown
- 2002-01-10 JP JP2002557379A patent/JP2004517883A/ja not_active Withdrawn
- 2002-01-10 CA CA002435121A patent/CA2435121A1/en not_active Abandoned
- 2002-01-10 IL IL15608702A patent/IL156087A0/xx unknown
- 2002-01-10 HU HU0302767A patent/HUP0302767A2/hu unknown
- 2002-01-10 KR KR10-2003-7009493A patent/KR20030069216A/ko not_active Ceased
- 2002-01-10 BR BR0206502-9A patent/BR0206502A/pt not_active IP Right Cessation
- 2002-01-10 EE EEP200300335A patent/EE200300335A/xx unknown
- 2002-01-10 WO PCT/IB2002/000042 patent/WO2002056871A2/en not_active Ceased
- 2002-01-10 OA OA1200300174A patent/OA12440A/en unknown
- 2002-01-10 CZ CZ20031853A patent/CZ20031853A3/cs unknown
- 2002-01-10 EP EP02732099A patent/EP1353657A1/en not_active Withdrawn
- 2002-01-10 PL PL02362793A patent/PL362793A1/pl not_active Application Discontinuation
- 2002-01-10 SK SK857-2003A patent/SK8572003A3/sk unknown
- 2002-01-10 CN CNA028036840A patent/CN1486178A/zh active Pending
- 2002-01-10 MX MXPA03006408A patent/MXPA03006408A/es unknown
- 2002-01-11 DO DO2002000325A patent/DOP2002000325A/es unknown
- 2002-01-14 PA PA20028537101A patent/PA8537101A1/es unknown
- 2002-01-14 PY PY200200200477A patent/PY0200477A/es unknown
- 2002-01-16 GT GT200200003A patent/GT200200003A/es unknown
- 2002-01-16 TN TNTNSN02003A patent/TNSN02003A1/fr unknown
- 2002-01-16 SV SV2002000849A patent/SV2003000849A/es not_active Application Discontinuation
- 2002-01-16 AR ARP020100145A patent/AR032101A1/es not_active Application Discontinuation
- 2002-01-17 AP APAP/P/2002/002401A patent/AP2002002401A0/en unknown
2003
- 2003-05-15 IS IS6818A patent/IS6818A/is unknown
- 2003-05-21 BG BG107834A patent/BG107834A/bg unknown
- 2003-05-22 CR CR6983A patent/CR6983A/es not_active Application Discontinuation
- 2003-05-29 ZA ZA200304180A patent/ZA200304180B/en unknown
- 2003-07-11 MA MA27233A patent/MA26980A1/fr unknown
- 2003-07-16 NO NO20033223A patent/NO20033223D0/no not_active Application Discontinuation
- 2003-07-17 EC EC2003004692A patent/ECSP034692A/es unknown

Also Published As

Publication number	Publication date
IL156087A0 (en)	2003-12-23
SV2003000849A (es)	2003-01-13
MXPA03006408A (es)	2003-10-15
PL362793A1 (pl)	2004-11-02
BR0206502A (pt)	2003-10-21
CR6983A (es)	2003-11-25
GB0101223D0 (en)	2001-02-28
SK8572003A3 (en)	2004-07-07
NO20033223L (no)	2003-07-16
PY0200477A (es)	2004-06-01
BG107834A (bg)	2004-01-30
PA8537101A1 (es)	2002-08-29
CN1486178A (zh)	2004-03-31
KR20030069216A (ko)	2003-08-25
MA26980A1 (fr)	2004-12-20
EE200300335A (et)	2003-12-15
CA2435121A1 (en)	2002-07-25
ZA200304180B (en)	2004-06-15
TNSN02003A1 (fr)	2005-12-23
DOP2002000325A (es)	2003-01-31
ECSP034692A (es)	2003-08-29
AR032101A1 (es)	2003-10-22
EP1353657A1 (en)	2003-10-22
WO2002056871A2 (en)	2002-07-25
OA12440A (en)	2006-05-22
JP2004517883A (ja)	2004-06-17
IS6818A (is)	2003-05-15
GT200200003A (es)	2002-08-19
NO20033223D0 (no)	2003-07-16
EA200300537A1 (ru)	2004-02-26
HUP0302767A2 (hu)	2003-11-28
CZ20031853A3 (cs)	2004-07-14

Publication	Publication Date	Title
GB0115862D0 (en)	2001-08-22	Compounds
AU2426602A (en)	2002-05-27	Piperazinylpyrazine compounds as agonist or antagonist of serotonin 5ht-2 receptor
ATE372768T1 (de)	2007-09-15	N-(2-arylethyl) benzylamine als 5-ht6 rezeptor- antagoniste
AU2002350961A1 (en)	2003-06-30	Ethylene diamine derivatives and their use as orexin-receptor antagonists
IL161074A0 (en)	2004-08-31	Lactam derivatives as antagonists for human 11cby receptors
PL362833A1 (pl)	2004-11-02	Połączenie antagonisty receptora CB1 i sibutraminy, kompozycje farmaceutyczne je zawierajace i ich zastosowanie do leczenia otyłości
ZA200408335B (en)	2005-11-02	Pyrrolidinium derivatives as antagonists of M3 muscarinic receptors.
AU7743001A (en)	2002-02-05	Cyclopentanoindoles, compositions containing such compounds and methods of treatment
MXPA03010134A (es)	2004-03-10	Derivados de ciclohexan-1-4-diamina sustituidos.
WO2005000820A3 (fr)	2005-03-17	Derives de 4-cyanopyrazole-3-carboxamide, leur preparation et leur application comme antagonistes des recepteurs aux cannabinoides cb1
BR0206595A (pt)	2004-07-13	Composto, composição farmacêutica, e uso de um composto
YU39803A (sh)	2006-05-25	Jedinjenja piperazinilpirazina kao agonisti ili antagonisti serotonin 5ht-2-receptora
PL371127A1 (pl)	2005-06-13	Pochodne 6-amino-morfinianu, metody ich otrzymywania oraz ich zastosowania
TWI256304B (en)	2006-06-11	Pharmaceutical compositions based on azetidine derivatives
AR032101A1 (es)	2003-10-22	Antagonistas de receptores de histamina
MXPA04004090A (es)	2004-07-08	Compuestos substituidos de 1h-quinolin-2-ona.
WO2002089740A3 (en)	2003-02-27	Sulfonamides
MXPA05012279A (es)	2006-02-10	Derivados de bencil sulfonamida.
WO2004043368A3 (en)	2004-07-22	Sulfonamides
WO2004043463A3 (en)	2004-06-17	Sulfonamides
UY27124A1 (es)	2002-08-30	Antagonistas de receptores de histamina
BR0113202A (pt)	2003-07-01	Compostos de trioxepano
林君	2003	marantz SR4400
AU2002250607A1 (en)	2002-11-05	8-aza-bicyclo(3.2.1)octan-3-ol derivatives of 2,3-dihydro-1,4-benzodioxan as 5-ht1a antagonists
ITVR20020030A0 (it)	2002-04-05	Miscela per polvere di saldatura, nonche procedimento per l'impiego di detta miscela.